Skip to main content

USANA HEALTH SCIENCES INC (USNA) Stock Forecast 2025 - AI Price Prediction & Analysis


USANA HEALTH SCIENCES INC (USNA) AI Stock Price Forecast & Investment Analysis

USANA HEALTH SCIENCES INC Stock Price Chart and Technical Analysis

Loading USANA HEALTH SCIENCES INC interactive price chart and technical analysis...

USANA HEALTH SCIENCES INC (USNA) - Comprehensive Stock Analysis & Investment Research

Deep dive into USANA HEALTH SCIENCES INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about USANA HEALTH SCIENCES INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For USANA HEALTH SCIENCES INC: USANA HEALTH SCIENCES INC operates in the Life Sciences sector, making it an emerging small-cap investment.

USANA HEALTH SCIENCES INC (Stock Symbol: USNA) is a leading company in the Life Sciences sector , specifically operating within the Medicinal Chemicals & Botanical Products industry.

The organization employs approximately 8320 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing USANA HEALTH SCIENCES INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For USANA HEALTH SCIENCES INC: With $271M in annual revenue and 20.0% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $271 million generating a 20.0% net profit margin .

Market Capitalization: $570 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 27.3% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for USANA HEALTH SCIENCES INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For USANA HEALTH SCIENCES INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for USANA HEALTH SCIENCES INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: USANA HEALTH SCIENCES INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For USANA HEALTH SCIENCES INC: Strong free cash flow generation demonstrates solid operational efficiency.

USANA HEALTH SCIENCES INC strategically competes in the highly dynamic Medicinal Chemicals & Botanical Products marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $108 million annually, complemented by impressive 26.6% year-over-year cash flow growth.

The company maintains a healthy 256.9% gross margin, indicating strong pricing power and operational efficiency.

USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for USANA HEALTH SCIENCES INC stock analysis.

Loading USANA HEALTH SCIENCES INC comprehensive fundamental analysis and insider trading data...

Deep dive into USANA HEALTH SCIENCES INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if USANA HEALTH SCIENCES INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For USANA HEALTH SCIENCES INC: With a P/E ratio of 13.57, the market sees the stock as potentially undervalued.

P/E Ratio 13.57x
P/B Ratio 1.08x
Market Cap $570M
EPS $2.83
Book Value/Share $28.20
Revenue/Share $45.94
FCF/Share $6.98
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently USANA HEALTH SCIENCES INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For USANA HEALTH SCIENCES INC: An ROE of 27.3% demonstrates excellent shareholder value creation.

ROE 27.3%
ROA 18.7%
ROIC 26.3%
Gross Margin 256.9%
Operating Margin 30.4%
Net Margin 20.0%
EBT Margin 13.9%
Tax Rate 32.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess USANA HEALTH SCIENCES INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For USANA HEALTH SCIENCES INC: A current ratio of 2.30 indicates strong liquidity.

Current Ratio 2.30x
Quick Ratio 1.51x
Financial Leverage 1.47x
Interest Coverage -180.0x
Working Capital $257M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal USANA HEALTH SCIENCES INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For USANA HEALTH SCIENCES INC: Free cash flow of $108M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $121M
Free Cash Flow $108M
Capital Spending $-13M
OCF Growth YoY 26.6%
FCF Growth YoY 31.9%
FCF/Sales 9.4%
CapEx/Sales 1.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively USANA HEALTH SCIENCES INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For USANA HEALTH SCIENCES INC: An asset turnover of 1.99x demonstrates efficient asset utilization.

Asset Turnover 1.99x
Receivables Turnover 200.5x
Inventory Turnover 2.3x
Fixed Assets Turnover 11.6x
Days Sales Outstanding 2 days
Days Inventory 160 days
Payables Period 20 days
Cash Conversion Cycle 133 days
Understanding Financial Statement Data

What these metrics mean: Key figures from USANA HEALTH SCIENCES INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For USANA HEALTH SCIENCES INC: With annual revenue of $271M, USANA HEALTH SCIENCES INC demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $271M
Operating Income $82M
Net Income $54M
SG&A Expense $68M
Cost of Goods Sold $165M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 64%
Cash & Short-term Investments 42%
Total Liabilities 32%
Short-term Debt 2%
Accounts Receivable 1%
Inventory 17%
Dividend & Shareholder Information
Shares Outstanding 19M
Growth Metrics (YoY)
EPS Growth 9.0%

Latest USANA HEALTH SCIENCES INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting USANA HEALTH SCIENCES INC (USNA) stock price and investment outlook.

, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

, source: MarketWatch

Usana Health Sciences Inc. falls more than 4% in the extended session Thursday after the multi-level marketing company calls for lower 2023 sales and profit than Wall Street expected, saying it is ...

USANA HEALTH SCIENCES INC Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of USANA HEALTH SCIENCES INC against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAWH Unlock Forecast - 30 Days FREE Trial $153M x 5.6x
AIBT Unlock Forecast - 30 Days FREE Trial $0M x x
AYRWF Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BTMD Unlock Forecast - 30 Days FREE Trial $388M 15.7x -3.0x
CBDY Unlock Forecast - 30 Days FREE Trial $1M x x
CDXC Unlock Forecast - 30 Days FREE Trial $536M -666.2x 11.6x
CGC Unlock Forecast - 30 Days FREE Trial $202M -0.3x 0.4x
CRON Unlock Forecast - 30 Days FREE Trial $1023M 55.3x 0.9x
CURLF Unlock Forecast - 30 Days FREE Trial $2647M x 3.1x
CXXIF Unlock Forecast - 30 Days FREE Trial $41M x 1.4x
CYAN Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.3x
FTLF Unlock Forecast - 30 Days FREE Trial $120M 19.3x 3.1x
GHBWF Unlock Forecast - 30 Days FREE Trial $37M x 0.3x
GLASF Unlock Forecast - 30 Days FREE Trial $811M x 7.0x
GLUC Unlock Forecast - 30 Days FREE Trial $0M x x
JUSHF Unlock Forecast - 30 Days FREE Trial $141M x x
MNMD Unlock Forecast - 30 Days FREE Trial $803M -3.1x 4.3x
MTEX Unlock Forecast - 30 Days FREE Trial $18M -55.4x 2.4x
NAGE Unlock Forecast - 30 Days FREE Trial $799M 45.1x 12.4x
NAII Unlock Forecast - 30 Days FREE Trial $26M -3.3x 0.3x
RAJAF Unlock Forecast - 30 Days FREE Trial $1020M x x
RAPH Unlock Forecast - 30 Days FREE Trial $4M x x
SMFL Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
SNYR Unlock Forecast - 30 Days FREE Trial $33M -551.3x -2.1x
TCNNF Unlock Forecast - 30 Days FREE Trial $1448M x 1.2x
TCRG Unlock Forecast - 30 Days FREE Trial $16M x x
TLRY Unlock Forecast - 30 Days FREE Trial $684M -4.1x 0.3x
UPXI Unlock Forecast - 30 Days FREE Trial $279M -10.6x 150.7x
USNA Unlock Forecast - 30 Days FREE Trial $570M 13.6x 1.1x

Frequently Asked Questions - USANA HEALTH SCIENCES INC Stock Forecast

How accurate are USANA HEALTH SCIENCES INC stock predictions?

Our AI model demonstrates 32% historical accuracy for USNA predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence USANA HEALTH SCIENCES INC stock price forecasts?

Our analysis considers USANA HEALTH SCIENCES INC's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is USANA HEALTH SCIENCES INC a good investment in 2025?

Based on our AI analysis, USANA HEALTH SCIENCES INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are USANA HEALTH SCIENCES INC forecasts updated?

USANA HEALTH SCIENCES INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced USANA HEALTH SCIENCES INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for USANA HEALTH SCIENCES INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...